Hofmann’s work on ergot led him down a route of isolating and synthesizing its compounds. The focus was on making a respiratory and circulatory stimulant. “The new substance, nevertheless, aroused no special curiosity in our pharmacologists and medical professionals; testing was hence discontinued.” Despite the restrictions on individual use and https://medium.com/@LsdWorld/the-future-of-lsd-research-and-potential-medical-uses-40ebd16dd150